Proliferation in human bladder carcinoma measured by Ki-67 antibody labelling: its potential clinical importance

Area of Science:

• Oncology
• Immunohistochemistry
• Urothelial Carcinomas

Background:

• Ki-67 is a monoclonal antibody identifying a nuclear antigen in proliferating cells.
• Assessing cellular proliferation is crucial for understanding tumor behavior and prognosis.

Purpose of the Study:

• To evaluate the utility of Ki-67 antibody staining for assessing proliferation in primary human bladder tumors.
• To correlate Ki-67 index with established prognostic factors in bladder cancer.

Main Methods:

• Ki-67 antibody staining was performed on primary human bladder tumor samples from 64 patients.
• The Ki-67 index (percentage of positive cells) was calculated for 59 tumors.
• Statistical analysis was used to correlate Ki-67 index with T stage, histological grade, and disease invasiveness.

Main Results:

• A wide range of Ki-67 indices (3.0-65.8%, mean 20.2%) was observed.
• Ki-67 index significantly correlated with T stage (P=0.002) and histological grade (P<0.001).
• Invasive and metastatic bladder tumors exhibited significantly higher Ki-67 indices compared to non-invasive tumors.

Conclusions:

• Ki-67 antibody staining is a simple and effective method for assessing tumor cell proliferation in bladder cancer.
• The Ki-67 index serves as a valuable prognostic marker, correlating with tumor stage, grade, and invasiveness.
• This technique can be applied to small biopsy samples without requiring radioactive tracers.